title: HIV-2 in pregnancy: to treat or not to treat?
authors.forename: N A
authors.initials: NA
authors.lastname: Smith
authors.forename: J
authors.initials: J
authors.lastname: Kennedy
authors.forename: S
authors.initials: S
authors.lastname: Bewley
authors.forename: S
authors.initials: S
authors.lastname: O'Shea
authors.forename: G
authors.initials: G
authors.lastname: du Mont
authors.forename: N
authors.initials: N
authors.lastname: Berry
authors.forename: J
authors.initials: J
authors.lastname: Breuer
authors.forename: A
authors.initials: A
authors.lastname: de Ruiter
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D015498:HIV-2; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D015215:Zidovudine / Q000008:administration & dosage*
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine